Lorne Meikle

Biography

Mr. Meikle is currently the President and Chief Executive Officer of Management Dynamics Ltd., LOB Ordeins Inc., President and Chair of The Biotechnology Initiative (TBI), the former President & CEO of BCY LifeSciences Inc. (TSXV:BCY),and serves as a director on three other Boards. Mr. Meikle, was born and raised in Edmonton and is an economics graduate from the University of Manitoba. He has more than 40 years of senior management, marketing and sales management, and director experience in the health care industry. He was a member of the senior management groups at Glaxo Canada, Smith Kline and French, Ortho-McNeil and directed the International marketing program at Connaught Laboratories, now Sanofi Pasteur. In recent years he was President of TBI, before returning for a second term; Vice President, Immunovaccine Technologies Inc.; President and Chief Executive Officer of Seragen Biopharmaceuticals Ltd., the Canadian affiliate of Seragen Inc., now part of Ligand, Inc; CEO of GeneSense Technologies Inc., now part of Lorus Therapeutics; and chaired the steering committee for BIO 2002 in Toronto. Additionally, he was the President, Chief Executive Officer, Founder and a director of BioCatalyst Yorkton Inc., a venture management company that specialized in the formation of, and management of early-stage healthcare companies. Mr. Meikle resides in Toronto.

Research Interest

Business and Development